Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/04/24 → 30/09/26 |
Funding
- Chief Scientist Office: £14,400.75
- Chief Scientist Office: £358,998.68
MAC-Endo: a pilot randomised controlled trial of the efficacy of RRx-001 macrophage-targeted immunotherapy in the management of endometriosis-associated pain
- Horne, Andrew (Principal Investigator)
- Dhaun, Neeraj (Co-investigator)